London, England, United Kingdom In 2014 was created 4BIO Capital, which is appeared as VC. The fund was located in Europe if to be more exact in United Kingdom. The main office of represented VC is situated in the London.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the 4BIO Capital, startups are often financed by Woodford Investment Management, Syncona Partners LLP, ODYSSEE VENTURE. The meaningful sponsors for the fund in investment in the same round are UCL Technology Fund, Temasek Holdings, RTW Investments LLC. In the next rounds fund is usually obtained by Auven Therapeutics, AstraZeneca, Redmile Group.
The fund is generally included in less than 2 deals every year. The higher amount of exits for fund were in 2018. This 4BIO Capital works on 51 percentage points more the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 50 - 100 millions dollars. The high activity for fund was in 2017.
The fund has exact preference in some founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Therapeutics, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Orchard Therapeutics, Atara Biotherapeutics, Cellectis. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom.
This organization was formed by Andrey Kozlov, Dmitry Kuzmin. We also calculated 3 valuable employees in our database.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Beazley Group | England, London, United Kingdom |
| CMGE | China, Hong Kong, Hong Kong Island |
| Creador | Kuala Lumpur, Malaysia |
| Eastate | Stockholm, Stockholm County, Sweden |
| Enlightened Capital | - |
| Global eTrade Services (GeTS) | Central, Central Region, Singapore |
| Haitao Capital | China, Shanghai |
| iVentures Asia Ltd | China, Hong Kong, Hong Kong Island |
| JLL Partners | New York, New York, United States |
| MLS Players Association | Bethesda, Maryland, United States |
| NantMobile | California, Culver City, United States |
| Palladin Consumer Retail Partners | Boston, Massachusetts, United States |
| PensionDanmark | Copenhagen, Denmark, Hovedstaden |
| Rodman & Renshaw | New York, New York, United States |
| Segittur | Community of Madrid, Madrid, Spain |
| Shangshan Investment | China, Shanghai |
| Simpact VC | Mazowieckie, Poland, Warsaw |
| Strait Capital Investment Group | China, Shanghai |
| Winton Ventures | England, London, United Kingdom |
| ZL LLC | Nashville, Tennessee, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
SomaServe | $27M | 13 Nov 2023 | Cambridge, England, United Kingdom | ||
Ray Therapeutics | $100M | 16 May 2023 | San Diego, California, United States | ||
Ascend | $65M | 09 May 2023 | - | ||
Entact Bio | $81M | 06 Dec 2022 | Watertown, Massachusetts, United States | ||
Araris Biotech | $24M | 04 Oct 2022 | Zurich, Zurich, Switzerland | ||
SparingVision | $88M | 14 Sep 2022 | Paris, Ile-de-France, France | ||
Code Biotherapeutics | $75M | 07 Jun 2022 | Hatfield, Pennsylvania, United States | ||
LUCA Science | $35M | 06 Jun 2022 | Chiyoda, Japan | ||
Ray Therapeutics | $6M | 04 Jan 2022 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
SomaServe | $27M | 13 Nov 2023 | Cambridge, England, United Kingdom | ||
Ray Therapeutics | $100M | 16 May 2023 | San Diego, California, United States | ||
Ascend | $65M | 09 May 2023 | - | ||
Entact Bio | $81M | 06 Dec 2022 | Watertown, Massachusetts, United States | ||
Araris Biotech | $24M | 04 Oct 2022 | Zurich, Zurich, Switzerland | ||
SparingVision | $88M | 14 Sep 2022 | Paris, Ile-de-France, France | ||
Code Biotherapeutics | $75M | 07 Jun 2022 | Hatfield, Pennsylvania, United States | ||
LUCA Science | $35M | 06 Jun 2022 | Chiyoda, Japan | ||
Ray Therapeutics | $6M | 04 Jan 2022 | San Diego, California, United States |
